320 related articles for article (PubMed ID: 25939597)
1. Two susceptibility loci identified for prostate cancer aggressiveness.
Berndt SI; Wang Z; Yeager M; Alavanja MC; Albanes D; Amundadottir L; Andriole G; Beane Freeman L; Campa D; Cancel-Tassin G; Canzian F; Cornu JN; Cussenot O; Diver WR; Gapstur SM; Grönberg H; Haiman CA; Henderson B; Hutchinson A; Hunter DJ; Key TJ; Kolb S; Koutros S; Kraft P; Le Marchand L; Lindström S; Machiela MJ; Ostrander EA; Riboli E; Schumacher F; Siddiq A; Stanford JL; Stevens VL; Travis RC; Tsilidis KK; Virtamo J; Weinstein S; Wilkund F; Xu J; Lilly Zheng S; Yu K; Wheeler W; Zhang H; ; Sampson J; Black A; Jacobs K; Hoover RN; Tucker M; Chanock SJ
Nat Commun; 2015 May; 6():6889. PubMed ID: 25939597
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations in the 3q26.31-32 locus confer an aggressive prostate cancer phenotype.
Simpson BS; Camacho N; Luxton HJ; Pye H; Finn R; Heavey S; Pitt J; Moore CM; Whitaker HC
Commun Biol; 2020 Aug; 3(1):440. PubMed ID: 32796921
[TBL] [Abstract][Full Text] [Related]
3. Replication study of 34 common SNPs associated with prostate cancer in the Romanian population.
Jinga V; Csiki IE; Manolescu A; Iordache P; Mates IN; Radavoi D; Rascu S; Badescu D; Badea P; Mates D
J Cell Mol Med; 2016 Apr; 20(4):594-600. PubMed ID: 26773531
[TBL] [Abstract][Full Text] [Related]
4. Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer.
Darst BF; Saunders E; Dadaev T; Sheng X; Wan P; Pooler L; Xia LY; Chanock S; Berndt SI; Wang Y; Patel AV; Albanes D; Weinstein SJ; Gnanapragasam V; Huff C; Couch FJ; Wolk A; Giles GG; Nguyen-Dumont T; Milne RL; Pomerantz MM; Schmidt JA; Travis RC; Key TJ; Stopsack KH; Mucci LA; Catalona WJ; Marosy B; Hetrick KN; Doheny KF; MacInnis RJ; Southey MC; Eeles RA; Wiklund F; Conti DV; Kote-Jarai Z; Haiman CA
JAMA Oncol; 2023 Nov; 9(11):1514-1524. PubMed ID: 37733366
[TBL] [Abstract][Full Text] [Related]
5. The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patients.
He Y; Gu J; Strom S; Logothetis CJ; Kim J; Wu X
Clin Cancer Res; 2014 Oct; 20(19):5133-5139. PubMed ID: 25274378
[TBL] [Abstract][Full Text] [Related]
6. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.
Zheng SL; Sun J; Cheng Y; Li G; Hsu FC; Zhu Y; Chang BL; Liu W; Kim JW; Turner AR; Gielzak M; Yan G; Isaacs SD; Wiley KE; Sauvageot J; Chen HS; Gurganus R; Mangold LA; Trock BJ; Gronberg H; Duggan D; Carpten JD; Partin AW; Walsh PC; Xu J; Isaacs WB
J Natl Cancer Inst; 2007 Oct; 99(20):1525-33. PubMed ID: 17925536
[TBL] [Abstract][Full Text] [Related]
7. Replication and cumulative effects of GWAS-identified genetic variations for prostate cancer in Asians: a case-control study in the ChinaPCa consortium.
Wang M; Liu F; Hsing AW; Wang X; Shao Q; Qi J; Ye Y; Wang Z; Chen H; Gao X; Wang G; Chu LW; Ding Q; OuYang J; Gao X; Huang Y; Chen Y; Gao YT; Zhang ZF; Rao J; Shi R; Wu Q; Zhang Y; Jiang H; Zheng J; Hu Y; Guo L; Lin X; Tao S; Jin G; Sun J; Lu D; Zheng SL; Sun Y; Mo Z; Yin C; Zhang Z; Xu J
Carcinogenesis; 2012 Feb; 33(2):356-60. PubMed ID: 22114074
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer.
FitzGerald LM; Kwon EM; Conomos MP; Kolb S; Holt SK; Levine D; Feng Z; Ostrander EA; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1196-203. PubMed ID: 21467234
[TBL] [Abstract][Full Text] [Related]
9. Synergistic Interaction of
Sipeky C; Gao P; Zhang Q; Wang L; Ettala O; Talala KM; Tammela TLJ; Auvinen A; Wiklund F; Wei GH; Schleutker J
Clin Cancer Res; 2018 Dec; 24(24):6265-6276. PubMed ID: 30181389
[TBL] [Abstract][Full Text] [Related]
10. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
11. Replication of prostate cancer risk loci in a Japanese case-control association study.
Yamada H; Penney KL; Takahashi H; Katoh T; Yamano Y; Yamakado M; Kimura T; Kuruma H; Kamata Y; Egawa S; Freedman ML
J Natl Cancer Inst; 2009 Oct; 101(19):1330-6. PubMed ID: 19726753
[TBL] [Abstract][Full Text] [Related]
12. Genetic susceptibility loci, pesticide exposure and prostate cancer risk.
Koutros S; Berndt SI; Hughes Barry K; Andreotti G; Hoppin JA; Sandler DP; Yeager M; Burdett LA; Yuenger J; Alavanja MC; Beane Freeman LE
PLoS One; 2013; 8(4):e58195. PubMed ID: 23593118
[TBL] [Abstract][Full Text] [Related]
13. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.
Fitzgerald LM; Kwon EM; Koopmeiners JS; Salinas CA; Stanford JL; Ostrander EA
Clin Cancer Res; 2009 May; 15(9):3231-7. PubMed ID: 19366831
[TBL] [Abstract][Full Text] [Related]
14. 8q24 and 17q prostate cancer susceptibility loci in a multiethnic Asian cohort.
Chan JY; Li H; Singh O; Mahajan A; Ramasamy S; Subramaniyan K; Kanesvaran R; Sim HG; Chong TW; Teo YY; Chia SE; Tan MH; Chowbay B
Urol Oncol; 2013 Nov; 31(8):1553-60. PubMed ID: 22561070
[TBL] [Abstract][Full Text] [Related]
15. Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease.
Sipeky C; Tammela TLJ; Auvinen A; Schleutker J
Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1158-1166. PubMed ID: 34012061
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility loci associations with prostate cancer risk in northern Chinese men.
Wang NN; Xu Y; Yang K; Wei D; Zhang YG; Liu M; Shi XH; Liang SY; Sun L; Zhu XQ; Yang YG; Tang L; Zhao CX; Wang X; Chen X; Hui J; Zhang YH; Zhu L; Yang F; Zhang YR; Yang Z; Wang JY
Asian Pac J Cancer Prev; 2013; 14(5):3075-8. PubMed ID: 23803082
[TBL] [Abstract][Full Text] [Related]
17. Podocalyxin variants and risk of prostate cancer and tumor aggressiveness.
Casey G; Neville PJ; Liu X; Plummer SJ; Cicek MS; Krumroy LM; Curran AP; McGreevy MR; Catalona WJ; Klein EA; Witte JS
Hum Mol Genet; 2006 Mar; 15(5):735-41. PubMed ID: 16434482
[TBL] [Abstract][Full Text] [Related]
18. Circadian genes polymorphisms, night work and prostate cancer risk: Findings from the EPICAP study.
Wendeu-Foyet MG; Cénée S; Koudou Y; Trétarre B; Rébillard X; Cancel-Tassin G; Cussenot O; Boland A; Olaso R; Deleuze JF; Blanché H; Lamy PJ; Mulot C; Laurent-Puig P; Truong T; Menegaux F
Int J Cancer; 2020 Dec; 147(11):3119-3129. PubMed ID: 32506468
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.
Klein RJ; Hallden C; Gupta A; Savage CJ; Dahlin A; Bjartell A; Manjer J; Scardino PT; Ulmert D; Wallström P; Vickers AJ; Lilja H
Eur Urol; 2012 Mar; 61(3):471-7. PubMed ID: 22101116
[TBL] [Abstract][Full Text] [Related]
20. Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel.
Leongamornlert DA; Saunders EJ; Wakerell S; Whitmore I; Dadaev T; Cieza-Borrella C; Benafif S; Brook MN; Donovan JL; Hamdy FC; Neal DE; Muir K; Govindasami K; Conti DV; Kote-Jarai Z; Eeles RA
Eur Urol; 2019 Sep; 76(3):329-337. PubMed ID: 30777372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
